Key Segmentation:
By Product Type
-
EEG Devices
-
Sleep Monitoring Devices
-
MEG Devices
-
ICP and TCD Devices
-
Others
By Application
-
Traumatic Brain Injury
-
Epilepsy
-
Dementia
-
Sleep Disorders
-
Stroke
-
Others
By End User
-
Hospitals and Neurology Centers
-
Research Institutes
-
Home Care Settings
-
Others
By Connectivity
-
Bluetooth Low Energy
-
Wi-Fi
-
NFC
-
Others
Regional Coverage:
North America
-
United States
-
Canada
Europe
-
Germany
-
United Kingdom
-
France
-
Italy
-
Spain
-
Russia
-
Poland
-
Rest of Europe
Asia Pacific
-
China
-
India
-
Japan
-
South Korea
-
Australia
-
ASEAN Countries
-
Rest of Asia Pacific
Middle East & Africa
-
UAE
-
Saudi Arabia
-
Qatar
-
South Africa
-
Rest of Middle East & Africa
Latin America
-
Brazil
-
Argentina
-
Mexico
-
Colombia
-
Rest of Latin America
Available Customization:
With the given market data, SNS Insider offers customization as per the company’s specific needs. The following customization options are available for the report:
-
Detailed Volume Analysis
-
Criss-Cross segment analysis (e.g. Product X Application)
-
Competitive Product Benchmarking
-
Geographic Analysis
-
Additional countries in any of the regions
-
Customized Data Representation
-
Detailed analysis and profiling of additional market players
Frequently Asked Questions
Key players include Ceribell, Zeto, Epitel, NextSense, Nihon Kohden, Interaxon (Muse), Neurable, Beacon Biosignals, Brain Products, EMOTIV, g.tec medical engineering, Bitbrain, OpenBCI, Mentalab, BrainScope, NeuroSky, Cognixion and Wearable Sensing.
Key opportunities include home and remote EEG, artificial intelligence-based bedside monitoring, consumer neurotechnology and low-cost tools for regions with few neurologists.
The rising burden of neurological disease, together with demand for faster and more portable brain monitoring, is the main growth factor.
By Product Type, the EEG Devices segment dominated the market in 2025 with an estimated 47.83% share, supported by its use as the first test for seizures and many other brain conditions.
North America dominated the market with a share of 43.60% in 2025, driven by a high burden of brain injury and dementia, shortages of EEG technologists and strong neurotechnology funding.